NCT04478838View on ClinicalTrials.gov

"Extended (Alternate Day) Antipsychotic Dosing"

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Schizophrenia and Related DisordersDrug Administration ScheduleDrug TherapyAntipsychotic Agents
Interventions
DRUG

Risperidone

0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg Tablets

DRUG

Olanzapine

2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg Tablets

DRUG

paliperidone

3 mg, 6 mg, 9 mg Tablets

Trial Locations (1)

M5T 1R8

RECRUITING

Centre for Addiction and Mental Health, Toronto

All Listed Sponsors
lead

Centre for Addiction and Mental Health

OTHER